TALIS BIOMEDICAL CORP
TLIS stock holders 13F
1 superinvestor reported owning TLIS (Common Stock) according to the gurus' 2022 Q2 report.
Top gurus who own (TLIS) TALIS BIOMEDICAL CORP
The 1 super investor (holders) owning TLIS (by the percentage (%) of portfolio) is David Einhorn - Greenlight Capital (0.14%) as of the 2022 Q2 report.
To check the latest activities of the top TLIS shareholders between value investors, please click on the "Activity" tab.
To see the historical data of TLIS's holders please click on the "2022 Q2" dropdown menu and select the date.
Current price: $1.69 86.13%
Reported hold price*: $12.18
Shares, change to shares, sold shares - split-adjusted.
Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.